Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05075980 · ClinicalTrials.gov registry record · Phase 2
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
A Phase 2 study of Head and Neck Carcinoma and Oropharyngeal Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 174
- Enrollment target
- 9
- Study locations
NCT05075980 is a Phase 2 study of Head and Neck Carcinoma and Oropharyngeal Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 174 participants, below the 408-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (57% lower). The trial reports 9 study locations across 4 states.
The verdict
NCT05075980, a Phase 2 study of Head and Neck Carcinoma and Oropharyngeal Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 174 participants
- Enrollment target
- 9
- Study locations
Study Summary
This clinical trial studies how well intensity modulated proton therapy (IMPT) or intensity modulated X-ray (radiation) therapy (IMRT) works after surgery in treating patients with head and neck cancer. IMPT is a type of radiation therapy that allows for the most accurate application of proton radiation to the tumor and has the potential to reduce treatment-related side effects. IMRT is a type of 3-dimensional radiation therapy that uses computer-generated images to show the size and shape of the tumor. Thin beams of x-ray radiation of different intensities are aimed at the tumor from many angles. This type of radiation therapy reduces the damage to healthy tissue near the tumor. IMPT may work as well as IMRT after surgery in treating patients with head and neck cancer.
Conditions Studied
Interventions
- PROCEDURE Computed Tomography
- DRUG Cisplatin
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- PROCEDURE Intensity-Modulated Proton Therapy
Study Locations (9)
Minnesota
- Mayo Clinic Health System in Albert Lea - Albert Lea
- Mayo Clinic Health System - Mankato - Mankato
- Mayo Clinic Radiation Therapy - Northfield - Northfield
- Mayo Clinic in Rochester - Rochester
Arizona
- Mayo Clinic Hospital in Arizona - Phoenix
- Mayo Clinic in Arizona - Scottsdale
Wisconsin
- Mayo Clinic Health System - Eau Claire - Eau Claire
- Mayo Clinic Health System - Franciscan Healthcare - La Crosse
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2022-02-16 |
| Est. Completion | 2035-11-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05075980
The ClinicalTrials.gov registry entry for NCT05075980 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 408-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (57% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Head and Neck Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Computed Tomography is the first listed.
NCT05075980 reports 9 study locations spanning 4 distinct geographic areas - top geographies include Minnesota, Arizona, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05075980 about?
NCT05075980 is a clinical study titled "Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study". This clinical trial studies how well intensity modulated proton therapy (IMPT) or intensity modulated X-ray (radiation) therapy (IMRT) works after surgery in treating patients with head and neck cancer. IMPT is a type of radiation therapy that allows for the most accurate application of proton radia...
What is the current status of trial NCT05075980?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 174 participants. The study started on 2022-02-16. Estimated completion is 2035-11-15.
What conditions does trial NCT05075980 study?
This clinical trial studies the following conditions: Head and Neck Carcinoma, Oropharyngeal Carcinoma, Head and Neck Carcinoma of Unknown Primary, Oral Cavity Carcinoma, Metastatic Malignant Neoplasm in the Lymph Nodes.
What interventions are being tested in trial NCT05075980?
The interventions under investigation include: Computed Tomography (PROCEDURE), Cisplatin (DRUG), Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Intensity-Modulated Proton Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT05075980?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05075980 being conducted?
This trial has 9 study locations across Arizona, Florida, Minnesota, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
RECRUITING · Phase 2
-
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
RECRUITING · Phase 2
-
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
RECRUITING · Phase 2
-
Interdisciplinary Interventions to Address Pain Management Among Head and Neck Cancer Patients
ACTIVE NOT RECRUITING · Phase 2
-
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
COMPLETED · Phase 2
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.